DaVita Inc. 3rd Quarter 2026 Results
Stocks in this Quantisnow insightHealth Care
Historical context for DVA
Across the 23 sessions after earlier DVA headlines, the stock closed higher 14 times and lower 9 times, with a median move of 1.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | DVA | SPY |
|---|---|---|---|
| Oct 27, 2026 | DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks | -1.3% | +0.6% |
| Oct 21, 2026 | DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice | +0.8% | +0.5% |
| Oct 20, 2026 | DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call | -6.2% | +0.3% |
| Oct 15, 2026 | DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care | +4.7% | +0.3% |
| Oct 9, 2026 | DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early | +1.3% | +0.6% |
| Aug 26, 2026 | Alebund Pharmaceuticals Announces 2026 Interim Results | +1.3% | +0.0% |
Quantisnow market dataNYSE
DVA
DaVita Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
Get push alerts for DVA
Full DVA profile on Quantisnow Follow DVA and get a push notification the moment its next story breaks.